Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2023 Mar 31;12(3):676-679.
doi: 10.21037/tcr-22-2892. Epub 2023 Feb 20.

Improved diagnostic accuracy of hybrid positron emission tomography (PET) with tumor-specific radiotracer for head and neck squamous cell carcinoma staging

Grégoire B Morand  1   2   3 , Martin W Huellner  2   4
Affiliations
Editorial

Improved diagnostic accuracy of hybrid positron emission tomography (PET) with tumor-specific radiotracer for head and neck squamous cell carcinoma staging

Grégoire B Morand et al. Transl Cancer Res. .
No abstract available

Keywords: 18-fluorodeoxyglucose (18F); panitumumab; squamous cell carcinoma of head and neck; tumor hypoxia; zirconium-89.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at https://tcr.amegroups.com/article/view/10.21037/tcr-22-2892/coif). MWH is a recipient of grants from GE Healthcare, grants for translational and clinical cardiac and oncological research from the Alfred and Annemarie von Sick legacy, and grants from the CRPP Artificial Intelligence in oncological Imaging Network by the University of Zurich. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The other author has no conflicts of interest to declare.

Comment on

Similar articles

See all similar articles

References

    1. Lee YJ, van den Berg NS, Duan H, et al. 89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma. Clin Cancer Res 2022;28:4425-34. 10.1158/1078-0432.CCR-22-0094 - DOI - PubMed
    1. Beyer T, Townsend DW, Brun T, et al. A combined PET/CT scanner for clinical oncology. J Nucl Med 2000;41:1369-79. - PubMed
    1. Kyzas PA, Evangelou E, Denaxa-Kyza D, et al. 18F-fluorodeoxyglucose positron emission tomography to evaluate cervical node metastases in patients with head and neck squamous cell carcinoma: a meta-analysis. J Natl Cancer Inst 2008;100:712-20. 10.1093/jnci/djn125 - DOI - PubMed
    1. Stadler TM, Morand GB, Rupp NJ, et al. FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors. Head Neck 2021;43:2058-68. 10.1002/hed.26668 - DOI - PubMed
    1. Kwee TC, Basu S, Cheng G, et al. FDG PET/CT in carcinoma of unknown primary. Eur J Nucl Med Mol Imaging 2010;37:635-44. 10.1007/s00259-009-1295-6 - DOI - PMC - PubMed